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The topic of the function and formation of the epidermal
permeability barrier continue to be an important issue to
understand regulation and development of the normal and
abnormal epidermis. A major player in the formation of the
barrier, i.e., the stratum corneum (SC), is a tubular and/or
ovoid-shaped membrane-bound organelle that is unique to
mammalian epidermis. In the past, this organelle has been
embellished largely with descriptive names attributed to
its perceived functional properties like membrane coating
granule, keratinosome, cementsoms, and lamellar body/
granule (LB). Over the last decade, data from several
laboratories documented that mammalian LB contain not
only pro-barrier lipids and their respective lipid processing
enzymes (e.g., b-glucocerebrosidase, acidic sphingomyeli-
nase, secretory phospholipase A2) destined for extrusion
into the extracellular environment at the apical portion of the
flattened stratum granulosum (SG) cell (Menon et al, 1992),
but additionally they contain proteases (SC chymotryptic
enzyme, cathepsin D, acid phosphatase, glycosidases,
protease inhibitors). Thus, LB are involved in barrier home-
ostasis, desquamation, formation of the cornified envelope
and additionally antimicrobial defence (Oren et al, 2003).
Thus, the heterogeneous content of LB is consistent with
the host of defensive function mediated by the SC (for a
review see Elias and Feingold, 2004, in press).
The LB transport the pro-barrier lipids (Grayson et al,
1985) to the apical regions of the outermost SG cell, often
forming deep invaginations of the stratum granulosum–SC
interface (Elias et al, 1998), facilitating rapid extrusion of
their contents which is there transformed into barrier lipids.
In skin diseases with involvement of epidermis and/or
barrier alterations, either of hereditary or inflammatory
origin, LB formation, morphology, kinetics of secretion and
extrusion mechanisms can be disturbed and can be used
as morphologic markers for diagnosis (Fartasch et al, 1992,
1999; Menon et al, 1992; Elias et al, 2000). Thus, the number
of functions linked to this fascinating organelle still
continues to increase.
The LB is believed to be something of a cross between a
secretory vesicle and a lysosome (Wolff and Holubar, 1967;
Madison, 2003). While it encapsulates several hydrolases
typical of lysosomes, it lacks other classic lysosomal
markers such as aryl sulfatase A/B and b-glucuronidase.
Moreover, it lacks lysosomal membrane markers, such as
LAMP-1. Instead, it expresses caveolin—a cholesterol-
binding scaffold protein that facilitates the assembly of
cholesterol—and sphingolipids into localized membrane
domains or ‘‘rafts’’ (Sando et al, 2003), which typically serve
as targets for apical transport of vesicles of Golgi origin. To
date, a large body of evidence supports the concept that
LB, which shows morphology ranging from vesicles to
tubules on EM, are probably products of the tubulo-
vesicular elements of the trans-Golgi network (TGN) that
is a tubulated sorting and delivery portion of the Golgi
apparatus (Elias et al, 1998; Madison, 2003). Recently,
some authors have hypothesized (Norlen, 2001) that LB are
not found as discrete organelles, but rather they comprise
a branched TGN system with lipid content that unfurls/
unfolds into the extracellular space in a non-energy
dependent, purely physical–chemical manner. But to date
there is neither immunoelectron microscopic evidence nor
functional tests with barrier disruption that support this
model. Moreover, this model does not deal with evidence
that LB formation and secretion are both energy dependent
(e.g., LB do not form at 41C) and regulated processes; e.g.,
LB secretion is blocked by classic inhibitors, such as
brefeldin A and momensin, and further regulated by
changes in external calcium.
In this Issue of the Journal of Investigative Dermatology,
Ishida-Yamamoto et al try to clarify the localization and
timing of LB content formation, providing evidence that
different content markers are distributed in a separated
population of LB molecules within the upper layers of
epidermis. In general, the interpretation of immunoelectron
microscopy studies regarding LB are difficult to interpret,
as there is not yet a definitive marker for LB other than
the demonstration of their internal membrane structure
by osmium tetroxide—or ruthenium tetroxide—staining. A
combination of criteria that includes size, shape, general
structural morphology and their occurrence in the upper
stratum spinosum and stratum granulosum is also used to
identify LB by immunoelectron microscopy, where preser-
vation of the LB membranes still remain suboptimal. In this
study, the authors could show that different functional areas
could exist within the branched tubular system that
comprise extension of the trans-Golgi network and by
applying different morphologic techniques (immunofluores-
cence microscopy and immunoelectron microscopy on
ultrathin cryosections) the authors identified co-localization
and localization of a variety of putative lamellar-body-
associated antigens which they believe localize to cargo
structures consistent with LB and TGN. Carefully inter-
preted, this study appears to provide evidence that LB
Abbreviation: EM, electron microscopy; LB, lamellar body; SC,
stratum corneum; SG, stratum granulosum; TGN, trans-Golgi
network.
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secretion is a finely tuned, complex mechanism, whereby
assembling of different cargos into LB occurs in a com-
partmentalized fashion. Indeed, the study by Yamamoto
et al provides further evidence that this unique secretory
system deserves careful study and abundant respect.
DOI: 10.1111/j.0022-202X.2004.22541.x
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